Consensus disease definitions for ophthalmic immune-related adverse events of immune checkpoint inhibitors.
Chang EL, Liu R, Keyhanian K, Huynh K, Berkenstock M, Bhatti MT, Chen JJ, Chodosh J, Costello F, Dalvin LA, DeLott LB, Dinkin M, Egan RA, Fraser CL, Freitag SK, Gangaputra S, Gordon LK, Guidon AC, Johnson DB, Kombo N, Kramer M, Lee AG, Levy M, Lobo-Chan AM, Mantopoulos D, Papaliodis G, Pless M, Pimkina J, Rubin KM, Sen HN, Shariff A, Subramanian PS, Tsui E, Yoon MK, McDunn J, Rine J, Reynolds KL, Sobrin L, Chwalisz BK.
Tirthani E, Said MS, Smith RG, Jadhav N, Shanina E.
2023 Jun 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
PMID:33232100
Central nervous system immune-related disorders after SARS-CoV-2 vaccination: a multicenter study.
Vogrig A, Tartaglia S, Dentoni M, Fabris M, Bax F, Belluzzo M, Verriello L, Bagatto D, Gastaldi M, Tocco P, Zoccarato M, Zuliani L, Pilotto A, Padovani A, Villagrán-García M, Davy V, Gigli GL, Honnorat J, Valente M.
Front Immunol. 2024 Feb 5;15:1344184. doi: 10.3389/fimmu.2024.1344184. eCollection 2024.
PMID:38375477
Rapid Immunodot AQP4 Assay for Neuromyelitis Optica Spectrum Disorder.
Fu Y, Bi J, Yan Y, Sun X, Li K, Kim SY, Han SM, Zhou L, Li R, Huang Q, Wang N, Lin A, Kim HJ, Qiu W.
JAMA Neurol. 2023 Oct 1;80(10):1105-1112. doi: 10.1001/jamaneurol.2023.2974.
PMID:37669037
Immune-related biomarkers in the neuromyelitis optica spectrum disorder; pathogenesis and therapeutic approaches.